Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Tonghua Dongbao Pharmaceutical Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Tonghua Dongbao Pharmaceutical Co Ltd (600867) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥62.99 Million ≈ $9.22 Million USD) by net assets (CN¥7.14 Billion ≈ $1.04 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)

Cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. This chart illustrates how Tonghua Dongbao Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Tonghua Dongbao Pharmaceutical Co Ltd stock quote for real-time trading data and today's change.

Tonghua Dongbao Pharmaceutical Co Ltd Cash Flow Conversion Ratio Explained

Tonghua Dongbao Pharmaceutical Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Tonghua Dongbao Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tonghua Dongbao Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see Tonghua Dongbao Pharmaceutical Co Ltd market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Ternium Argentina SA
BA:TXAR
0.014x
Pertamina Geothermal Energy
JK:PGEO
0.033x
Compagnie Financiere Tradition
SW:CFT
0.099x
Ningbo Jintian Copper Group Co Ltd
SHG:601609
-0.009x
Data Patterns (India) Limited
NSE:DATAPATTNS
-0.032x
Douzone Bizon Co Ltd
KO:012510
0.036x
Shanghai Flyco Electrical Appliance Co Ltd
SHG:603868
0.085x
NBCC (India) Limited
NSE:NBCC
-0.384x

Annual Cash Flow Conversion Efficiency for Tonghua Dongbao Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of Tonghua Dongbao Pharmaceutical Co Ltd from 1998 to 2025. Review Tonghua Dongbao Pharmaceutical Co Ltd (600867) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥7.11 Billion
≈ $1.04 Billion
CN¥689.23 Million
≈ $100.86 Million
0.097x +35.00%
2024-12-31 CN¥6.40 Billion
≈ $936.58 Million
CN¥459.74 Million
≈ $67.27 Million
0.072x -39.83%
2023-12-31 CN¥7.22 Billion
≈ $1.06 Billion
CN¥861.52 Million
≈ $126.07 Million
0.119x -9.40%
2022-12-31 CN¥6.55 Billion
≈ $958.41 Million
CN¥863.09 Million
≈ $126.30 Million
0.132x -27.75%
2021-12-31 CN¥6.22 Billion
≈ $910.21 Million
CN¥1.13 Billion
≈ $166.02 Million
0.182x -14.95%
2020-12-31 CN¥5.56 Billion
≈ $813.52 Million
CN¥1.19 Billion
≈ $174.47 Million
0.214x -6.77%
2019-12-31 CN¥5.01 Billion
≈ $732.95 Million
CN¥1.15 Billion
≈ $168.60 Million
0.230x +24.18%
2018-12-31 CN¥4.73 Billion
≈ $692.77 Million
CN¥876.94 Million
≈ $128.32 Million
0.185x -12.56%
2017-12-31 CN¥4.54 Billion
≈ $663.97 Million
CN¥961.19 Million
≈ $140.65 Million
0.212x +15.15%
2016-12-31 CN¥3.95 Billion
≈ $577.31 Million
CN¥725.76 Million
≈ $106.20 Million
0.184x +54.81%
2015-12-31 CN¥2.48 Billion
≈ $362.76 Million
CN¥294.58 Million
≈ $43.11 Million
0.119x +24.69%
2014-12-31 CN¥2.16 Billion
≈ $316.15 Million
CN¥205.89 Million
≈ $30.13 Million
0.095x -13.08%
2013-12-31 CN¥2.02 Billion
≈ $295.04 Million
CN¥221.06 Million
≈ $32.35 Million
0.110x +12.35%
2012-12-31 CN¥1.99 Billion
≈ $291.37 Million
CN¥194.32 Million
≈ $28.44 Million
0.098x +468.21%
2011-12-31 CN¥2.08 Billion
≈ $304.07 Million
CN¥-55.07 Million
≈ $-8.06 Million
-0.027x -128.63%
2010-12-31 CN¥1.73 Billion
≈ $253.53 Million
CN¥160.40 Million
≈ $23.47 Million
0.093x -9.39%
2009-12-31 CN¥1.63 Billion
≈ $238.04 Million
CN¥166.20 Million
≈ $24.32 Million
0.102x +58.67%
2008-12-31 CN¥1.43 Billion
≈ $209.78 Million
CN¥92.31 Million
≈ $13.51 Million
0.064x -18.33%
2007-12-31 CN¥1.53 Billion
≈ $224.47 Million
CN¥120.94 Million
≈ $17.70 Million
0.079x -36.33%
2006-12-31 CN¥1.28 Billion
≈ $186.72 Million
CN¥158.00 Million
≈ $23.12 Million
0.124x +80.01%
2005-12-31 CN¥1.34 Billion
≈ $196.19 Million
CN¥92.23 Million
≈ $13.50 Million
0.069x +592.91%
2004-12-31 CN¥1.33 Billion
≈ $194.05 Million
CN¥13.17 Million
≈ $1.93 Million
0.010x -69.43%
2003-12-31 CN¥1.40 Billion
≈ $205.04 Million
CN¥45.51 Million
≈ $6.66 Million
0.032x +38.36%
2002-12-31 CN¥1.36 Billion
≈ $199.45 Million
CN¥31.99 Million
≈ $4.68 Million
0.023x -72.51%
2001-12-31 CN¥1.38 Billion
≈ $201.72 Million
CN¥117.73 Million
≈ $17.23 Million
0.085x +317.87%
2000-12-31 CN¥1.43 Billion
≈ $208.52 Million
CN¥29.12 Million
≈ $4.26 Million
0.020x +130.19%
1999-12-31 CN¥1.40 Billion
≈ $205.54 Million
CN¥-95.09 Million
≈ $-13.91 Million
-0.068x +71.02%
1998-12-31 CN¥928.90 Million
≈ $135.93 Million
CN¥-216.98 Million
≈ $-31.75 Million
-0.234x --

About Tonghua Dongbao Pharmaceutical Co Ltd

SHG:600867 China Drug Manufacturers - Specialty & Generic
Market Cap
$2.28 Billion
CN¥15.59 Billion CNY
Market Cap Rank
#5528 Global
#970 in China
Share Price
CN¥7.96
Change (1 day)
-0.87%
52-Week Range
CN¥7.37 - CN¥10.49
All Time High
CN¥23.57
About

Tonghua Dongbao Pharmaceutical Co., Ltd. researches, develops, produces, and markets pharmaceuticals in China. It offers human insulin injections; insulin glargine injections; insulin aspart injections; liraglutide injections; and proprietary Chinese medicine. The company also provides insulin pen and pen needles; and chronic disease management platform, a diabetes management platform for drug tr… Read more